The studies provided do not directly investigate curcumin or its role in antioxidant support — rather, they examine computational drug repurposing models for COVID-19 and the antiviral potential of a furocoumarin compound derived from Angelica archangelica. Research suggests that while these studies touch on related themes of disease biology and natural compound bioactivity, none of them assess curcumin's antioxidant properties in human or animal models. The available evidence base here consists of preclinical and computational work, none of which can be used to draw conclusions about curcumin's antioxidant effects. Readers interested in curcumin and antioxidant support should consult literature that directly investigates this compound and outcome, as the studies linked here do not provide a meaningful basis for summarizing that relationship.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Modeling COVID-19 disease biology to identify drug treatment candidates | Other | 2022 | Neutral | 85 |
| Natural and synthetic potential inhibitors of endoribonuclease Nsp15 encoded ... | Other | 2020 | — | 80 |
| First-described recently discovered non-toxic vegetal-derived furocoumarin pr... | Other | 2020 | Neutral | 75 |